Marcin Poręba
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 11
- Oncology top 5%
- Peptidase Inhibition and Analysis 21
- Molecular Biology top 5%
- Cell death mechanisms and regulation 11
- Natural product bioactivities and synthesis 6
- Biochemical and Structural Characterization 6
- RNA Interference and Gene Delivery 5
- Chemical Synthesis and Analysis 5
- Immunology top 10%
- Organic Chemistry top 5%
- Click Chemistry and Applications 8
Marcin Poręba
61 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 390
- Oncology 659
- Molecular Biology 1.4k
- Immunology 328
- Organic Chemistry 355
Countries citing papers authored by Marcin Poręba
This map shows the geographic impact of Marcin Poręba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Poręba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Poręba more than expected).
Fields of papers citing papers by Marcin Poręba
This network shows the impact of papers produced by Marcin Poręba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Poręba. The network helps show where Marcin Poręba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marcin Poręba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 18 | |
| 8 | 2020 | 42 | |
| 9 | 2018 | 14 | |
| 10 | 2018 | 0 | |
| 11 | 2018 | 82 | |
| 12 | 2017 | 0 | |
| 13 | 2017 | 59 | |
| 14 | 2017 | 81 | |
| 15 | 2017 | 5 | |
| 16 | 2015 | 21 | |
| 17 | 2014 | 33 | |
| 18 | 2012 | 22 | |
| 19 | 2012 | 19 | |
| 20 | 2011 | 17 |
About Marcin Poręba
Marcin Poręba is a scholar working on Cancer Research, Oncology, Molecular Biology, Microbiology and Immunology, having authored 68 papers that have together received 2.2k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (21 papers), Cell death mechanisms and regulation (11 papers), Protease and Inhibitor Mechanisms (11 papers), Click Chemistry and Applications (8 papers), Natural product bioactivities and synthesis (6 papers), Biochemical and Structural Characterization (6 papers), RNA Interference and Gene Delivery (5 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Cancer Research (390 citations), Oncology (659 citations), Molecular Biology (1.4k citations), Immunology (328 citations) and Organic Chemistry (355 citations). Marcin Poręba has collaborated with scholars based in Poland, United States and Slovenia. Frequent co-authors include Marcin Drąg, Guy S. Salvesen, Paulina Kasperkiewicz, Scott J. Snipas, Katarzyna Groborz, Wioletta Rut, Boris Turk, Vito Türk, Christine C. Winterbourn and Heather A. Parker. Their work appears in journals such as Chemical Science, Journal of Biological Chemistry, FEBS Journal, Biological Chemistry and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.